Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma.

Cancers (Basel) · 2019 · PMC6966586 · PMID 31842413

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approached significanceno p-value reported

Somewhat encouragingly, the extended survival times of animals, that tolerated the combination treatment in vivo, approached significance when compared with vehicle cohort.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.